Brief: Interpace Biosciences Q4 Revenue USD 10.283 Million
Mar 07 (Reuters) - Interpace Biosciences Q4 operating income USD 1.312 million. * Q4 net income USD 889 thousand * Q4 gross profit USD 6.136 million * Q4 operating expenses USD 4.824 million * Q4 net income continuing operations USD 813 thousand
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million